Skip to main content
SpringerLink
Log in

Treatment Options for Hairy Cell Leukemia

  • Conference paper
Interferons

  • 96 Accesses

Abstract

Hairy cell leukemia (HCL) is a rare B-cell lymphoproliferative disorder, first described as a separate entity in 1958 and named in 1966 for the characteristic leukemic cell cytoplasmic protrusions seen on light microscopy of peripheral blood and bone marrow smears [1]. Despite its rarity, HCL has been of great interest to hematologists because of the evolution of successful management which has increased survival time from a median of 53 months without treatment [2] to approximate that of an age-matched cohort.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bouroncle BA (1994) Thirty-five years in the progress of hairy cell leukemia. Leuk Lymphoma 14 [Suppl1]: 1–12

    PubMed  Google Scholar 

  2. Golomb HM, Catovsky D, Golde DW (1978) Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med 89: 677–693

    PubMed  CAS  Google Scholar 

  3. Lauria F, Benfenati D, Raspadori D, Rondelli D, Zinzani L, Tura S (1993) High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosine. Leuk Lymphoma 11: 399–404

    Article  PubMed  CAS  Google Scholar 

  4. Dann E J, Gillis S, Rachmilewitz A, Barak V, Cass Y, Ruchlemer R, Polliak A (1994) Hairy cell leukemia: results of 2-chlorodeoxyadenosine therapy in Jerusalem. Leuk Lymphoma 14 [Suppl 1]: 127–131

    PubMed  Google Scholar 

  5. Golomb HM, Vardiman J (1993) Hairy cell leukemia. In: Holland JF, Frei E, Bast RC et al (eds) Cancer Medicine, 3rd edn. Lea and Febiger, Philadelphia

    Google Scholar 

  6. Kampmeier P, Spielberger R, Dickstein J, Mick R, Golomb HM, Vardiman JW (1994) Increased incidence of second neoplasms in patients treated with interferon α2b for hairy cell leukemia. A clinicopathological assessment. Blood 83: 2931–2938

    PubMed  CAS  Google Scholar 

  7. Trussard X, Henry-Amar M, Flandrin G (1994) Second cancer risk after interferon therapy (letter)? Blood 84: 3242–3244

    Google Scholar 

  8. Golomb HM (1994) Do we know the treatment of choice for hairy cell leukemia? Ann Oncol 5: 676–677.

    PubMed  CAS  Google Scholar 

  9. Spielberger RT, Mick R, Ratain MJ, Golomb HM (1994) Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983–1986. Leuk Lymphoma 14 [Suppl 1]: 89–93

    PubMed  Google Scholar 

  10. Troussard X, Flandrin G (1994) Hairy cell leukemia. An update on a cohort of 93 patients treated in a single institution. Effects of interferon in patients relapsing after splenectomy and in patients with or without maintenance treatment. Leuk Lymphoma 14 [Suppl 1]: 99–105

    PubMed  Google Scholar 

  11. Federico M, Frassoldati A, Lamparelli T et al (1994) Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL. Ann Oncol 5: 725–731

    PubMed  CAS  Google Scholar 

  12. Pittaluga S, Verhoef G, Maes A, Boogaerts MA, De Wolf-Peeters C (1994) Bone marrow trephines; findings in patients with hairy cell leukemia before and after treatment. Histopathology 25: 129–135

    Article  PubMed  CAS  Google Scholar 

  13. Gutterman JU (1994) Cytokine therapeutics: lessons from interferon α. Proc Natl Acad Sci USA 91: 1198–1205

    Article  PubMed  CAS  Google Scholar 

  14. Rozenblum E, Larripa I, Barazzutti L, Rendo P, Avalos JS (1994) Interferon DNA polymorphism in chronic leukemia. Leuk Lymphoma 13: 99–103

    Article  PubMed  CAS  Google Scholar 

  15. Tallman MS, Hakimian D (1995) Purine nucleotide analogs: emerging roles in indolent lymphoproliferative disorders. Blood 86: 2463–2474

    PubMed  CAS  Google Scholar 

  16. Saven A, Piro L (1994) Newer purine analogues for the treatment of hairy-cell leukemia. N Engl J Med 330: 691–697

    Article  PubMed  CAS  Google Scholar 

  17. Golomb HM, Dodge R, Mick R, Budman D, Hutchison R, Horning SJ, Schiffer CA (1994) Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515. Leukemia 8: 2037–2040

    PubMed  CAS  Google Scholar 

  18. Annino L, Ferrari A, Giona F et al (1994) Deoxycoformycin induces long-lasting remissions in hairy cell leukemia: clinical and biological results of two different regimens. Leuk Lymphoma 14 [Suppl 1]: 115–119

    PubMed  Google Scholar 

  19. Saven A, Piro LD (1993) Complete remissions in hairy cell leukemia with 2-chlorodeoxyadenosine after failure with 2’-deoxycoformycin. Ann Intern Med 119: 278–283

    PubMed  CAS  Google Scholar 

  20. Piro LD, Carrera CJ, Carson DA, Beutier E (1990) Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 322: 1117–1121

    Article  PubMed  CAS  Google Scholar 

  21. Piro LD, Ellison DJ, Saven A (1994) The Scripps Clinic experience with 2-chlorodeoxyadenosine in the treatment of hairy cell leukemia. Leuk Lymphoma 14 [Suppl 1]: 121–125

    PubMed  Google Scholar 

  22. Tallman MS, Hakimian D, Dyrda S, Kiley C, Nemcek A, Peterson L (1994) Assessment of complete remission after 2-chlorodeoxyadenosine for hairy cell leukemia: utility of marrow immunostaining and measurement of splenic index. Leuk Lymphoma 14 [Suppl 1]: 133–138

    PubMed  Google Scholar 

  23. Pileri S, Sabattini E, Poggi S et al (1994) Bone marrow biopsy in hairy cell leukemia patients. Histological and immunohistochemical analysis of 46 cases treated with different therapies. Leuk Lymphoma 14 [Suppl 1]: 67–71

    PubMed  Google Scholar 

  24. Di Celle PF, Reato G, Raspadori D et al (1994) Molecular evaluation of clonal remission in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine Leuk Lymphoma 14 [Suppl 1]: 139–142

    PubMed  Google Scholar 

  25. Kraut EH (1994) Cross-resistance to purine analogs in hairy cell leukemia (letter). Ann Intern Med 120: 247–248

    PubMed  CAS  Google Scholar 

  26. Kraut EH, Hoo GC (1991) Fludarabine phosphate in refractory hairy cell leukemia. Am J Hematol 37: 59–60

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. C. S. Zent
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. M. Golomb
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Heinrich-Heine-Universität Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany

    Carlo Aul  & Wolfgang Schneider  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Zent, C.S., Golomb, H.M. (1997). Treatment Options for Hairy Cell Leukemia. In: Aul, C., Schneider, W. (eds) Interferons. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60411-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60411-9_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-61051-9

  • Online ISBN: 978-3-642-60411-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation